Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report
Journal Information
Full Title: Turk J Haematol
Abbreviation: Turk J Haematol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of Interest: No conflict of interest was declared by the authors."
Funding Disclosure
Evidence found in paper:
"Financial Disclosure: This work was supported by the Dongcheng District Outstanding Talent Nurturing Program (grant 2022-dchrcpyzz-69 to L.Z.), the National High Level Hospital Clinical Research Funding (grant 2022-PUMCH-A-021 to L.Z.), and the Research and Translation Application of Beijing Clinical Diagnostic Technologies Funds from the Beijing Municipal Commission of Science and Technology (grant Z211100002921016 to L.Z.)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025